← Back to Clinical Trials
Recruiting NCT06616506

Artificial Intelligence for Highly Myopic Cataract

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Cataract
Sponsor Shanghai High Myopia Study Group
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2016-01-01
Completion 2030-12-31
Interventions
newly-invented AI model

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to establish a multi-center artificial intelligence model for the accurate calculation of intraocular lens and its clinical application in highly myopic cataract, so as to improve the accuracy of the prediction of postoperative diopter in highly myopic cataract patients.

Eligibility Criteria

Inclusion Criteria: Axial length ≥ 26 mm and patients with high myopia complicated by cataracts who visit our hospital. Preoperative anterior segment photography and cataract severity assessment, along with fundus OCT examination, have been performed. If surgical treatment is conducted, the postoperative follow-up period should be no less than 1 month. There are no missing clinical data before and after the surgery. Exclusion Criteria: Patients who are unable to cooperate with the required examinations for this study.

Related Trials

}
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology